Pharmaceutical companies and public health officials gather at the IFPMA Assembly to urge for greater innovation and private and public partnerships to address global health concerns.
Nov 7, 2012
By:
Patricia Van Arnum
Pharmaceutical companies and public health officials gather at the IFPMA Assembly to urge for greater innovation and private and public partnerships to address global health concerns.
|
Nov 6, 2012
By:
Patricia Van Arnum
Watson Pharmaceuticals has completed its EUR 4.25 billion ($5.4 billion) acquisition of the Actavis Group. The combination creates the world's third largest generic-drug pharmaceutical company, with anticipated pro forma combined 2012 revenues in excess of $8 billion, according to Watson.
|
|
Pharmaceutical companies and contract service providers adapt strategies and capabilities to reduce costs and accelerate drug-development timelines.
Nov 2, 2012
By:
Patricia Van Arnum
Pharmaceutical companies and contract service providers adapt strategies and capabilities to reduce costs and accelerate drug-development timelines.
|
|
The promise of antibody drug conjugates is creating a network of partners among large pharma companies and specialized players.
Nov 2, 2012
By:
Patricia Van Arnum
The promise of antibody drug conjugates is creating a network of partners among large pharma companies and specialized players.
|
|
Developing analytical methods and performing related testing is crucial for ensuring the quality of a pharmaceutical product. This analysis is applied to identify and characterize the active ingredient, the finished drug product, and impurities that may be present in the drug substance and finished drug product. In this technical forum, several industry experts offer case studies in pharmaceutical analysis.
Nov 1, 2012
By:
Patricia Van Arnum
Developing analytical methods and performing related testing is crucial for ensuring the quality of a pharmaceutical product.
|
Oct 23, 2012
By:
Patricia Van Arnum
Ben Venue Laboratories has resumed production on a limited number of manufacturing lines in the company's Bedford, Ohio, facilities.
|
Oct 10, 2012
By:
Patricia Van Arnum
The PTE team is currently in Madrid attending numerous meetings and presentations at CPhI and its collocated events. Read the thoughts of our editor on the highlights of the show so far.
|
Oct 9, 2012
By:
Patricia Van Arnum
Over the years, CPhI has expanded to cover several areas connected with pharmaceutical manufacturing, but one of the prime focuses of the show is still on ingredients, fine chemicals and intermediates. PharmTech Europe’s exceutive editor, Patricia Van Arnum, tells us more.
|
A recent review evaluates the nature of global health partnerships and critical factors for their success.
Oct 3, 2012
By:
Patricia Van Arnum
A recent review evaluates the nature of global health partnerships and critical factors for their success.
|
|
